Circulating HIV Type 1 Drug Resistance Will Have Limited Impact on the Effectiveness of Preexposure Prophylaxis among Young Women in Zimbabwe | Zendy

David van de Vijver | Zendy; Inge Derdelinckx | Zendy; Charles A. Boucher | Zendy

Open Access

Circulating HIV Type 1 Drug Resistance Will Have Limited Impact on the Effectiveness of Preexposure Prophylaxis among Young Women in Zimbabwe

Author(s) -

David van de Vijver,

Inge Derdelinckx,

Charles A. Boucher

Publication year - 2009

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/597804

Subject(s) - human immunodeficiency virus (hiv) , drug , pre exposure prophylaxis , medicine , drug resistance , hiv drug resistance , intensive care medicine , immunology , pharmacology , biology , men who have sex with men , antiretroviral therapy , viral load , microbiology and biotechnology , syphilis

Preexposure prophylaxis (PrEP) with antiretroviral drugs may prevent transmission of human immunodeficiency virus (HIV). Our objective was to predict whether PrEP, in the presence of circulating drug resistance, will reduce the risk of infection with HIV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research